---
{"dg-publish":true,"permalink":"/USMLE/Blood/Fibrinolysis/","tags":["t1"]}
---

# Fibrinolytic therapy
---
- Agents: Fibrinolytics promote the degradation of thrombi by activating plasminogen to plasmin.
- Adverse effects
	- Bleeding (e.g., intracranial hemorrhage)
- Reversal of adverse effects
	- <span style="background:rgba(240, 200, 0, 0.2)">Antifibrinolytics: group of drugs that impair fibrinolysis, typically by interfering with plasmin formation</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Tranexamic acid: a synthetic lysine analog and inhibitor of plasminogen with antifibrinolytic action</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Aminocaproic acid</span>: a lysine derivative and inhibitor of plasminogen activators and plasmin with antifibrinolytic action

